Covid-19 vaccine boosts Pfizer's results

A pallet of Pfizer BioNTech vaccines against Covid-19.

AP - Francisco Seco

Text by: RFI Follow

2 min

The more the months pass, the more the sales counter panics for the Pfizer laboratory.

The American published its quarterly results.

On the whole of its activities, it realized 18 billion 900 million dollars of turnover.

It is obviously the vaccine against the Covid that drives its sales.

And that's only the beginning.


Read more

The group plans to sell this year for 33.5 billion dollars of this product developed in partnership with the German BioNTech.

$ 33.5 billion!

This is much more than what Pfizer was hoping for last May.

Highly sought after for the effectiveness of its vaccine, the New York laboratory remains far, far ahead of its competitors.

By comparison, Johnson & Johnson anticipates $ 2.5 billion in revenue from the sale of its product this year. 

Knowing that the latter, like the Swedish-British AstraZeneca, have undertaken to sell their serum at cost price during the time of the pandemic. 

Vaccination campaigns

This is not the case with Pfizer's vaccine.

From 12 euros initially, its price has risen to 15 euros 50. And is close to 20 euros for orders from the European Commission which will be delivered in 2022.  

Thanks to vaccination campaigns that are being implemented around the world, the Pfizer group is increasing the number of contracts.

One of the latest includes 200 million additional doses for the United States.

Other orders will undoubtedly follow, if a third dose is necessary. 

► Read also: Covid-19: Pfizer will request authorization to administer a third dose of vaccine


Receive all international news directly in your mailbox

I subscribe

Follow all the international news by downloading the RFI application


  • Coronavirus

  • Health and medicine

  • Vaccines

On the same subject

Covid-19: European Medicines Agency authorizes Pfizer vaccine for 12-15 year olds

Pfizer-BioNTech to produce 100 million doses per year in South Africa

EU allows Pfizer vaccine to be stored in refrigerator for one month